Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Radiotherapy, Intensity-Modulated × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 23 Oropharyngeal Neoplasms 18 Prostatic Neoplasms 11 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Laryngeal Neoplasms 8 Head and Neck Neoplasms 8 Mouth Neoplasms 7 Carcinoma, Squamous Cell 7 Carcinoma 7 Hypopharyngeal Neoplasms 6 Glioblastoma 6 Breast Neoplasms 6 Uterine Cervical Neoplasms 5 Glioma 5 Esophageal Neoplasms 5 Papillomavirus Infections 4 Lung Neoplasms 4 Astrocytoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Nasopharyngeal Neoplasms 3 Lymphatic Metastasis 3 Leukemia, Myeloid, Acute 3 Endometrial Neoplasms 3 Anus Neoplasms 3 Tumor Virus Infections 2 Thyroid Carcinoma, Anaplastic 2 Sarcoma 2

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡